Sibylle C. Mellinghoff

4.9k total citations
56 papers, 1.0k citations indexed

About

Sibylle C. Mellinghoff is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Sibylle C. Mellinghoff has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 31 papers in Epidemiology and 16 papers in Oncology. Recurrent topics in Sibylle C. Mellinghoff's work include Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (17 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Sibylle C. Mellinghoff is often cited by papers focused on Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (17 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Sibylle C. Mellinghoff collaborates with scholars based in Germany, United States and Austria. Sibylle C. Mellinghoff's co-authors include Oliver A. Cornely, Philipp Koehler, Jon Salmanton‐García, Enrico Schalk, Marcus Hentrich, Georg Maschmeyer, Marie von Lilienfeld‐Toal, Dieter Buchheidt, Michael von Bergwelt‐Baildon and Anne Bergeron and has published in prestigious journals such as Blood, Cochrane Database of Systematic Reviews and Annals of Oncology.

In The Last Decade

Sibylle C. Mellinghoff

47 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sibylle C. Mellinghoff Germany 20 585 477 251 99 85 56 1.0k
Haim Ben‐Zvi Israel 17 623 1.1× 319 0.7× 198 0.8× 90 0.9× 68 0.8× 58 1.1k
Monica Fung United States 13 547 0.9× 310 0.6× 183 0.7× 45 0.5× 29 0.3× 31 942
Benjamin W. Teh Australia 23 474 0.8× 528 1.1× 590 2.4× 184 1.9× 41 0.5× 77 1.4k
Alex Carignan Canada 15 415 0.7× 380 0.8× 116 0.5× 96 1.0× 66 0.8× 47 1.0k
Kateri Heydon United States 12 531 0.9× 634 1.3× 104 0.4× 31 0.3× 23 0.3× 14 1.0k
Miguela A. Caniza United States 21 301 0.5× 431 0.9× 299 1.2× 210 2.1× 21 0.2× 72 1.3k
Katleen de Gaetano Donati Italy 19 755 1.3× 517 1.1× 73 0.3× 51 0.5× 14 0.2× 33 1.2k
M Giacchino Italy 17 463 0.8× 523 1.1× 365 1.5× 43 0.4× 10 0.1× 38 960
Philippe Ovetchkine Canada 18 304 0.5× 474 1.0× 54 0.2× 60 0.6× 28 0.3× 86 900
F. Raffi France 21 721 1.2× 734 1.5× 144 0.6× 69 0.7× 51 0.6× 71 1.5k

Countries citing papers authored by Sibylle C. Mellinghoff

Since Specialization
Citations

This map shows the geographic impact of Sibylle C. Mellinghoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibylle C. Mellinghoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibylle C. Mellinghoff more than expected).

Fields of papers citing papers by Sibylle C. Mellinghoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibylle C. Mellinghoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibylle C. Mellinghoff. The network helps show where Sibylle C. Mellinghoff may publish in the future.

Co-authorship network of co-authors of Sibylle C. Mellinghoff

This figure shows the co-authorship network connecting the top 25 collaborators of Sibylle C. Mellinghoff. A scholar is included among the top collaborators of Sibylle C. Mellinghoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibylle C. Mellinghoff. Sibylle C. Mellinghoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mellinghoff, Sibylle C., Martin Thelen, Michael von Bergwelt‐Baildon, et al.. (2025). Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD‐1 Inhibition as Potential Treatment Option. Mycoses. 68(3). e70044–e70044. 2 indexed citations
2.
Pana, Zoi Dorothea, Fabianne Carlesse, Danila Seidel, et al.. (2025). The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates. Mycoses. 68(3). e70041–e70041. 1 indexed citations
3.
Bethe, Ullrich, Peter Borchmann, Veronica Di Cristanziano, et al.. (2025). Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study. JMIR Research Protocols. 14. e60675–e60675.
4.
Kobbe, Guido, Tobias A.W. Holderried, Martina Crysandt, et al.. (2025). Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis. Blood Advances. 9(6). 1370–1375. 2 indexed citations
5.
Mellinghoff, Sibylle C., Sandra Robrecht, Rosanne Sprute, et al.. (2024). Hybrid immunity to SARS‐CoV ‐2 in patients with chronic lymphocytic leukemia. European Journal Of Haematology. 112(5). 788–793.
6.
Mayer, Leonie, Anahita Fathi, Maya Kono, et al.. (2024). MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans. npj Vaccines. 9(1). 20–20. 3 indexed citations
7.
Salmanton‐García, Jon, Philipp Koehler, Jan Grothe, et al.. (2024). The Cologne ECMM Excellence Center: A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections. Mycopathologia. 189(2). 25–25. 1 indexed citations
8.
9.
Trommer, Maike, Anne Adams, Stefanie Brunner, et al.. (2023). Impact of the COVID-19 pandemic on training conditions and education in oncologic disciplines: a survey-based analysis. Strahlentherapie und Onkologie. 199(9). 806–819. 2 indexed citations
10.
Rüthrich, Maria Madeleine, Nicola Giesen, Sibylle C. Mellinghoff, Christina Rieger, & Marie von Lilienfeld‐Toal. (2022). Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences. Vaccines. 10(2). 182–182. 12 indexed citations
11.
Piechotta, Vanessa, Sibylle C. Mellinghoff, Claire Iannizzi, et al.. (2022). Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review. Blood Cancer Journal. 12(5). 86–86. 25 indexed citations
12.
Mellinghoff, Sibylle C., et al.. (2022). Infektionsmanagement bei Immunsupprimierten. DMW - Deutsche Medizinische Wochenschrift. 147(13). 840–850.
13.
Fathi, Anahita & Sibylle C. Mellinghoff. (2021). Impfstoffe gegen COVID-19. Der Internist. 62(11). 1191–1201.
14.
Mellinghoff, Sibylle C., Martin Thelen, Christiane J. Bruns, et al.. (2021). T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option. Journal of Infection. 84(2). 237–247. 19 indexed citations
15.
16.
Cornely, Oliver A., Jon Salmanton‐García, Felix C. Koehler, et al.. (2020). Attributable mortality of candidemia after introduction of echinocandins. Mycoses. 63(12). 1373–1381. 31 indexed citations
17.
Stemler, Jannik, Jon Salmanton‐García, Danila Seidel, et al.. (2019). Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature. Mycoses. 63(3). 265–274. 14 indexed citations
18.
Koehler, Philipp, Sibylle C. Mellinghoff, Jannik Stemler, et al.. (2019). Quantifying guideline adherence in mucormycosis management using the EQUAL score. Mycoses. 63(4). 343–351. 11 indexed citations
19.
20.
Mellinghoff, Sibylle C., Pia Hartmann, Philipp Köhler, et al.. (2018). Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship. European Journal of Clinical Microbiology & Infectious Diseases. 37(8). 1563–1571. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haim Ben‐Zvi Breakdown of academic impact, for papers by Monica Fung Breakdown of academic impact, for papers by Benjamin W. Teh Breakdown of academic impact, for papers by Alex Carignan Breakdown of academic impact, for papers by Kateri Heydon Breakdown of academic impact, for papers by Miguela A. Caniza Breakdown of academic impact, for papers by Katleen de Gaetano Donati Breakdown of academic impact, for papers by M Giacchino Breakdown of academic impact, for papers by Philippe Ovetchkine Breakdown of academic impact, for papers by F. Raffi
Rankless by CCL
2026